Setting priorities for patient-centred surveillance of drug-resistant infections
03 June 2020
A priority-setting process (PSP) was launched to define priorities for patient-centred antimicrobial resistance (AMR) surveillance and research in low- and middle-income countries (LMICs). A list of uncertainties related to AMR surveillance in human health was generated using an online survey of stakeholders in LMICs which asked for unanswered questions about diagnosis, treatment or prevention of antibiotic resistance.
- Most clinicians in low- and middle-income countries (LMICs) lack local antimicrobial susceptibility data.
- Clinicians in LMICs do not feel confident to treat drug-resistant infections.
- Current guidance for infection prevention and control is not well adapted to low resource settings.
Further reading: International Journal of Infectious Diseases
Author(s): Elizabeth Ashley et al
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
